British Varsity Makes Stem Cells from Blood: Research

A new research by the University of Cambridge says that personalized stem cells can now be made using a patient's own blood, and doctors hope the cells will eventually be used to treat a range of diseases.

Experts say this could be one of the easiest and safest sources of stem cells, BBC reported Friday.

About Stem Cells
Encyclopedia section of medindia gives general info about Stem Cells

The cells were used to build blood vessels, but experts cautioned that the safety of using such stem cells was still unclear.

Stem cells are one of the great hopes of medical research. They can transform into any other type of cell the body is built from - so they should be able to repair everything from the brain to the heart, and eyes to bone, BBC said.

One source of stem cells is embryos, but this is ethically controversial and they would be rejected by the immune system in the same way as an organ transplant.

Role of Protein in the Development of Prostate Cancer Identified
Recent studies have indicated that the protein known as TRPM8 plays an important role in prostate cancer.

The team at Cambridge looked in blood samples for a type of repair cell that whizzes through the bloodstream repairing any damage to the walls of blood vessels. These were then converted into stem cells, the report said.

Researcher Amer Rana said this method was better than taking samples from skin.

Cloned Dogs to Be Mated as Test
The world's first cloned dog will be mated with the world's second dog clone, in an experiment to see whether they can reproduce normally.

"We are excited to have developed a practical and efficient method to create stem cells from a cell type found in blood," he said.

"Tissue biopsies are undesirable - particularly for children and the elderly - whereas taking blood samples is routine for all patients."

Canadian Scientists Create Human Cancer in Mouse
Canadian scientists claim to have injected human cancer into a mouse for the first time - to learn more about the disease in its earliest stages and how to stop its spread.

Chris Mason, an expert on regenerative medicine at University College London, said there was some "beautiful work" coming out of the lab in Cambridge.

"It's a hell of a lot easier to get a blood sample than a high quality skin sample, so that's a big benefit," he told BBC.

"However, induced pluripotent stem cells (those converted from adult cells) are still very new, we need far more experience to totally reprogram a cell in a way we know to be safe."

The British Heart Foundation also said these cells had "great potential".

Source-IANS